CSH1 and gestational diabetes: This is the first study to systematically quantitate the placental gene expression profiles of GH2, CSH1 and CSH2 alternative mRNA transcripts in cases of maternal complications pre-eclampsia (PE, symptoms > 34 week) and gestational diabetes mellitus (GD) in comparison with uncomplicated pregnancies.